Roche wins FDA approval for first molecular malaria blood donor screening test
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Roche has received Food and
Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Roche has received Food and
Wall Street analysts tipped 2024 as the year that medtech dealmaking would return after a two-year slowdown when companies were forced to navigate a tough economic
The financial ties between drug and device makers and some physicians remains pervasive, despite concerns such relationships may influence medical practice, according to a new
TORONTO, March 27, 2024 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research,
TAMPA – Psilera, a leading biotechnology company developing groundbreaking therapies for hard-to-treat neurological disorders, is pleased to announce the appointment of Magali Haas, M.D., Ph.D., to its
Share this article Laboratory equipment, instrumentation and consumables are critical in the research and development of novel medicines and vaccines. Lab equipment suppliers and procurement,
NEW YORK and BERLIN, March 28, 2024 (GLOBE NEWSWIRE) — atai Life Sciences (NASDAQ: ATAI) (“atai” or “Company”) a clinical-stage biopharmaceutical company aiming to transform the treatment
VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN), a leading Health Canada licensed psychedelics pharmaceutical
Share this article The CDC has identified 36 US states where less than 95% of children in kindergarten have been vaccinated against measles this year,
VANCOUVER, BC, March 28, 2024 /CNW/ – Filament Health Corp. (OTCQB: FLHLF) (Cboe CA: FH) (FSE: 7QS) (“Filament” or the “Company”), a clinical‐stage natural psychedelic drug development company, today